SBRT on Oligoprogressive Lesions: Benefit in Lung Cancer SBRT on Oligoprogressive Lesions: Benefit in Lung Cancer
Stereotactic body radiation therapy (SBRT) significantly improved progression-free survival in oligoprogressive, metastatic lung cancer, but not breast cancer.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Hematology | Lung Cancer | Radiation Therapy